azomycin has been researched along with Heart Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Barbosa, JMC; Cascabulho, CM; Daliry, A; de Melo, TG; de Oliveira, G; Pedra Rezende, Y; Pereira, ENGDS; Salem, KS | 1 |
| Fortaleza, CMCB; Nunes da Costa, EAP; Victória, C | 1 |
| Britto, C; Cruz Moreira, O; da Silva, AA; de Souza Ruivo, LA; Lannes-Vieira, J; Resende Pereira, I; Vilar-Pereira, G | 1 |
3 other study(ies) available for azomycin and Heart Diseases
| Article | Year |
|---|---|
Experimental Combination Therapy with Amiodarone and Low-Dose Benznidazole in a Mouse Model of Trypanosoma cruzi Acute Infection.
Topics: Amiodarone; Animals; Chagas Disease; Disease Models, Animal; Drug Therapy, Combination; Heart; Heart Diseases; Heart Function Tests; Humans; Male; Mice; Nitroimidazoles; Parasitemia; Trypanosoma cruzi | 2022 |
Predictors of development of cardiac and digestive disorders among patients with indeterminate chronic Chagas Disease.
Topics: Adult; Antiprotozoal Agents; Brazil; Chagas Disease; Chronic Disease; Digestive System Diseases; Female; Heart Diseases; Humans; Male; Middle Aged; Nitroimidazoles; Retrospective Studies; Trypanosoma cruzi | 2021 |
Combination Chemotherapy with Suboptimal Doses of Benznidazole and Pentoxifylline Sustains Partial Reversion of Experimental Chagas' Heart Disease.
Topics: Animals; Chagas Disease; Female; Flow Cytometry; Heart Diseases; Immunohistochemistry; Mice; Mice, Inbred C57BL; Nitroimidazoles; Pentoxifylline; Real-Time Polymerase Chain Reaction; Trypanocidal Agents; Trypanosoma cruzi | 2016 |